pharmaceutical-investing Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent
medical-device-investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
pharmaceutical-investing VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101
pharmaceutical-investing Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations
Rio Silver Launches Metallurgical Program to De-Risk Processing and Optimize Silver Recoveries at Maria Norte
